Amphetamines taken by any route can cause cerebral vasculitis and intracranial haemorrhage. 8 cases were seen in a neurosurgical unit over 3.5 years. The published work indicates that those who experience these complications, mainly young adults, have poor outcomes.
INTRODUCTION
The ®rst reported death from amphetamine abuse was in 1939, in a 25-year-old man who had taken the drug repeatedly as a stimulant before a college examination 1 . Intracerebral haemorrhage (ICH) from amphetamine abuse was ®rst described in 1945 2 , since when a further 36 cases have been reported 3±32 . Similar cases have been described after use of amphetamine-like stimulants such as ephedrine, phenylpropanolamine and 3,4-methylenedioxyamphetamine (`ecstasy') 33±36 .
We report 8 cases of ICH associated with amphetamine, seen in our neurosurgical unit in the past 3.5 yearsÐ4 analysed retrospectively and 4 prospectively. All patients underwent computed tomography (CT) and cerebral digital subtraction angiography (DSA). Table 1 lists presenting symptoms, CT scan appearances, angiographic ®ndings, diagnosis, therapy and outcome for each patient (numbers 38±45). 7 had a parenchymal haematoma (Figures 1 and 2 )Ð3 in the frontal lobe, 1 in the frontoparietal region, 1 in the parietal lobe, 1 in the temporal lobe and 1 in the brainstem. One patient had a subarachnoid haemorrhage (SAH). He also had`beading' of small and medium-sized arteries that persisted on follow-up ( Figure 3 ). DSAs in the remaining patients were unremarkable.
CASE SERIES
The time from exposure to onset of symptoms ranged from less than 10 minutes to about 2 months (median within 1 day). None of our patients had con®rmatory toxicological tests since all admitted to having abused amphetamine.
PREVIOUS REPORTS
The apparent increase in frequency of ICH associated with amphetamines and amphetamine-like agents presumably re¯ects an increase in use of these recreational drugs. Young people seem to be the main group at risk: only 4 reported cases were in people over 40 years (see Table 1 ). Taking our 8 cases in conjunction with the 37 previously reported, we ®nd a mean age of 28 years (median 26, range 16±60). Most patients were repeat abusers (31) but nearly one-third claimed to be ®rst-time or infrequent users. 57% had taken the drug orally, 34% intravenously (i.v.) and 5% by inhalation. One patient used the drug both i.v. and by inhalation, and in one the route was unknown. ICH is seen with all routes of intake.
Of the 25 patients who underwent CT examination, 21 (84%) had proven ICH (3 with additional SAH); 3 had SAH alone, and 1 had a brainstem haemorrhage. One patient, in whom CT was negative, had SAH con®rmed by lumbar puncture. In the 35 patients who underwent angiography, twenty examinations were normal (or revealed only mass effect from a haematoma), 16 showed vasculitic beading, and 1 showed arteriovenous malformation.
The effects of amphetamine abuse are reported elsewhere 37 . Kaufman et al. 38 have suggested that there is a wide margin of safety between a therapeutic and a toxic dose, and in many patients with ICH the event has followed prolonged usage 8, 15 . However, ICH has occurred in some individuals after a single low-dose exposure 3, 6, 9 .
The close temporal relation between exposure and the onset of ICH suggests that the cause is systemic hypertension induced by the drug 8, 11, 23 . Most of our patients presented with ICH within 24 hours. However, one case is described in which ICH occurred 2 years after the last amphetamine exposure and was thought to be associated with vasculitis 15 .
Angiography has two main purposes in these patientsÐ to identify any underlying structural abnormality 1 and to detect vasculitis. Use of amphetamine may provoke ICH in the presence of a structural abnormality such as an
S e p t e m b e r 2 0 0 0 aneurysm or arteriovenous malformation 11, 17, 23, 29 . Alternatively the fact that it has been used may be irrelevant, in a patient with spontaneous subarachnoid haemorrhage 39, 40 . Particularly in this young population, there should be a low threshold for repeat angiography for SAH because of the risks of missing an underlying abnormality in the presence of vascular spasm 39 .
The angiographic feature that is characteristic of vasculitis is extensive irregular segmental narrowing or beading of small arteries 41, 42 . This pattern of narrowing and dilatation is in contrast to the more usual involvement of the trunks of major cerebral arteries seen in subarachnoid haemorrhage, in which there is relative sparing of the distal branches. This angiographic pattern is not speci®c to amphetamine abuse and can be seen in abusers of other drugs 43 . Although vasculitis may follow only a single exposure 6 , repeated exposure to amphetamines is the usual history 14,38,44 . Conci et al. 6 believe that the vasculitis resolves spontaneously 6 ; Landi and Spickler 41 regard the changes in small and medium sized arteries as permanent (which might explain the occurrence of late bleeds). The causal mechanism of vasculitis is not known. If it is related to catecholamine release 44 , this might account for the similar angiographic pattern of medium and small vessel spasm sometimes seen with subarachnoid haemorrhage. An alternative explanation is that the vasculitis is due to contamination from microparticles in the injected solutes 8, 27, 45, 46 This could explain the similarities found between intravenous abusers of different substances but it does not account for the vessel changes seen in those using amphetamine by mouth or inhalation. Deranged cerebral blood¯ow has been observed in users of amphetamine and other drugs 43 but the severity is not related to the dose or the duration of exposure, nor are the blood vessel changes con®ned to the cerebral circulation 47 .
Work in animals has revealed immediate angiographic changes after exposure to amphetamine 48 . Affected vessels display ®brinoid angiitis, necrosis of the media and intima, leukocytic in®ltration and intimal proliferation 15 . Amphetamine may produce direct vessel damage causing platelet aggregations and/or serotonin release, with increased vascular permeability 41 .
Treatment must be decided case by case but is mainly supportive. Of the 45 cases reported (including our own series), 27 had purely supportive therapy; 9 had craniotomy for evacuation of haematoma. Full nursing care, reduction of blood pressure to normal and management of associated (possibly drug-related) disease are the key elements. Neurosurgical referral for possible intervention is appropriate; and, when ®t enough, patients should undergo cerebral angiography.
Whilst the reported cases are almost certainly biased towards the severely affected, the outcomes have been notably poor: 7 patients died and only 14 (32%) achieved a good recovery. Can the results be improved? Salanova and Tauber 28 favour urgent treatment of the vasculitis with cyclophosphamide (2 mg/kg per day), intravenous dexamethasone (24 mg/day i.v.) and prednisolone (50 mg/ day). The adverse factors probably go well beyond the obvious vascular lesions: this patient group is likely to have concurrent illnesses; there is the possibility of systemic as well as cerebral vascular damage 1, 11, 38, 47 ; and some patients will continue their drug habit on discharge. We should also not forget the possibility that some of these patients with ICH are victims of trauma 27 . The patient outcomes in the 45 published cases were described as normal in just 13.
CONCLUSION
ICH associated with amphetamine abuse causes a substantial number of deaths and considerable morbidity.
In a young patient the ®nding of a frontal or parietal lobar haematoma should raise suspicion that an amphetamine is responsible.
